Johnson & Johnson
Change company Symbol lookup
Select an option...
JNJ Johnson & Johnson
VIPS Vipshop Holdings Ltd
CAT Caterpillar Inc
AAPL Apple Inc
ESLT Elbit Systems Ltd
AZO Autozone Inc
DITTF Daito Trust Construction Co Ltd
MYO Myomo Inc
CRVS Corvus Pharmaceuticals Inc

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.


Last Trade
-0.46 (-0.32%)
B/A Size

Market Hours

Closing Price
Day's Change
0.33 (0.23%)
B/A Size
Day's High
Day's Low
(Above Average)

10-day average volume:

Six Agtech Startups Selected for Wells Fargo Innovation Incubator

8:00 am ET May 21, 2020 (BusinessWire) Print

The Wells Fargo Innovation Incubator (IN(2)), a technology incubator and platform funded by the Wells Fargo Foundation and co-administered by the U.S. Department of Energy's National Renewable Energy Laboratory (NREL), today announced that it has selected six new participating startups focused on agriculture technology solutions to join the program.

This press release features multimedia. View the full release here:

The new companies represent IN(2)'s seventh cohort and share a focus on developing technologies that support the agricultural sector while reducing environmental impact. Agtech investing has shown great promise even with current economic uncertainties. A recent market analysis predicts investment dollars to reach $6.9 billion this year, doubling since $3.4 billion in 2017. The IN(2)program expanded its focus to agtech in 2018 to address the growing impact of the agricultural sector on carbon emissions.

"On average, agriculture accounts for nearly 13% of global carbon emissions," said Ramsay Huntley, Sustainable Finance Strategist at Wells Fargo. "IN(2) is uniquely positioned to reduce the environmental impact of food production by validating promising, early-stage, sustainable agriculture technologies and accelerating their respective paths to commercialization."

The selected startups will conduct research and development activities at the Donald Danforth Plant Science Center in St. Louis, a program partner and the world's largest independent plant science institute. The program provides each company up to $250,000 in technical assistance with the opportunity for follow-on funding, and access to state-of-the-art expertise and resources from the Danforth Center, Wells Fargo, NREL and other IN(2) partners.

"The companies selected for Cohort 7 provide a window into the next chapter of agriculture. Their technologies are focused on optimizing efficiencies and scaling sustainable agricultural practices in order to feed a growing global population," said Trish Cozart, IN(2) program manager at NREL. "Our partners at Danforth are at the intersection of science, innovation and commercialization, and we're pleased to connect their deep domain expertise and robust research capabilities with sustainable startup innovations."

The selected companies include:

AgroSpheres - Charlottesville, VA - Transforming crop protection with AgriCell, a powerful enabling technology for the efficient and improved use of synthetic chemicals and biologicals. AgriCell can mitigate the direct and indirect detriments of using chemical pesticides, with the goal to cut chemical pesticide use by at least 50 percent. Chi Botanic - Sarasota, FL - Industrializing plant cell cultures as a production platform by replicating genetically identical plants at a large scale. The Chi Botanic technology will help develop valuable natural products more efficiently and cost-effectively. EarthSense - Champaign, IL - Revolutionizing the way crop breeders and farmers collect and use impactful data, EarthSense employs machine learning and robotics in the field to increase yield, eliminate resistant superweeds and accelerate crop improvement. mobius - Lenoir City, TN - Building a future where organic waste streams are upcycled into valuable chemical building blocks. mobius creates naturally biodegradable and compostable materials that can replace controlled-release fertilizers for improved plant and soil health. Pluton Biosciences - St. Louis, MO - Supplying the agricultural industry with microbes that are specifically targeted against various pests. By using a micromining process, Pluton Biosciences can help offset biological resistance that has been building against current products. TerViva - Oakland, CA - Commercializing climate-resilient pongamia trees, a hardy legume tree that produces an annual crop of beans up to 10 times greater than soy for over 25 years. TerViva is increasing the global supply of plant protein and vegetable oil while restoring degraded agricultural land.

The latest additions to the IN(2) portfolio were first nominated by a nationwide network of theprogram's Channel Partners, which include more than 60 cleantech and agtech business incubators, accelerators, universities and industry experts--before undergoing in-depth review by Wells Fargo, the Danforth Center, and IN(2)'s expert industry advisory board.

With the addition of these six companies, IN(2)'s total portfolio now includes 46 startups. Since joining the IN(2) program, portfolio companies have raised $313 million in external follow-on funding -- equivalent to an average of more than $28 for every $1 awarded by the incubator.

About the Wells Fargo Innovation Incubator (IN(2))

The Wells Fargo Innovation Incubator (IN(2)) is a $30 million technology incubator and platform funded by the Wells Fargo Foundation. Co-administered by and housed at the National Renewable Energy Laboratory (NREL) in Golden, Colorado, IN(2)'s mission is to speed the path to market for early-stage, clean-technology entrepreneurs. Launched in 2014 with an initial focus on supporting scalable solutions to reduce the energy impact of commercial buildings, IN(2) has since expanded its focus to advance technologies that address the sustainable production of agriculture and housing affordability. Companies selected for participation in the program receive up to $250,000 in non-dilutive funding from Wells Fargo, technical support and validation from experts at NREL and the Donald Danforth Plant Science Center, and ongoing connections to organizations across value chains. For more information, visit

About Wells Fargo

Wells Fargo & Company (NYSE: WFC) is a diversified, community-based financial services company with $1.98 trillion in assets. Wells Fargo's vision is to satisfy our customers' financial needs and help them succeed financially. Founded in 1852 and headquartered in San Francisco, Wells Fargo provides banking, investment and mortgage products and services, as well as consumer and commercial finance, through 7,400 locations, more than 13,000 ATMs, the internet ( and mobile banking, and has offices in 31 countries and territories to support customers who conduct business in the global economy. With approximately 263,000 team members, Wells Fargo serves one in three households in the United States. Wells Fargo & Company was ranked No. 29 on Fortune's 2019 rankings of America's largest corporations. News, insights and perspectives from Wells Fargo are also available at Wells Fargo Stories. Additional information may be found at | Twitter: @WellsFargo.

View source version on


Wells Fargo Media
E.J. Bernacki, 415-840-4469 

IN2 Media
Liz Crumpacker, 646-494-7482

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.